Report cover image

Feline Atopic Dermatitis Treatment Market

Publisher Future Market Insights
Published Jun 30, 2022
Length 250 Pages
SKU # FMARI18188395

Description

Feline Atopic Dermatitis Treatment Market


Feline atopic dermatitis is the inflammation of the skin seen in the cats. Feline atopic dermatitis is often triggered by causative allergens which are either inhaled or through skin contact leading to inflammation of the skin. As per the study carried out by the Canadian Veterinary Journal the conservative prevalence of the feline atopic dermatitis in the cats is around 12.5% whereas the actual prevalence is high as it is very common disorder in cats. The diagnosis of the often starts when itchy skin is observed in the cats. The feline atopic dermatitis treatment often involves the medications which help to decrease the immune response which causes pruritus. Various non-inflammatory drugs are also used in the feline atopic dermatitis treatment. Most often the feline atopic dermatitis is lifelong condition of inflamed skin, it may be seasonal or non-seasonal which leads to frequent visits to veterinarians for feline atopic dermatitis treatment.

Feline Atopic Dermatitis Treatment Market: Drivers and Restraints

High prevalence of atopic dermatitis among the cats irrespective of the region expected to drive the growth of the feline atopic dermatitis treatment market. Around 62.0% of U.S. households have one or more companion animals and it is expected to increase rapidly which in turn expected to drive the growth of the feline atopic dermatitis treatment market. Increasing trend of companion animals in regions such as Asia-Pacific and Latin America further expected to fuel the growth of the feline atopic dermatitis treatment market. Increasing diagnosis and subsequently increasing treatment seeking rate for various diseases in companion animals further expected to drive the growth of the feline atopic dermatitis treatment market. Increasing number of companion animals coupled with increasing number of veterinarians in the developing countries expected to drive the growth of the feline atopic dermatitis treatment market. Whereas, lack of novel treatment which can prevent the reoccurrence of the atopic dermatitis may hamper the growth of the feline atopic dermatitis treatment market.

Feline Atopic Dermatitis Treatment Market: Segmentation

The global feline atopic dermatitis treatment market is segmented on the basis of the drug class, route of administration, distribution channel and region

By drug class, the global feline atopic dermatitis treatment market is segmented as:
  • Corticosteroids
  • Antihistamines
  • Antibiotics
By route of administration, the global feline atopic dermatitis treatment market is segmented as:
  • Oral
  • Topical
  • Injectable
By distribution channel, the global feline atopic dermatitis treatment market is segmented as:
  • Veterinary Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Feline Atopic Dermatitis Treatment Market: Overview

The global feline atopic dermatitis treatment market is expected to experience significant growth due to increasing prevalence of the feline atopic dermatitis. By drug class, corticosteroids is expected to dominate the global feline atopic dermatitis treatment market by revenue due to higher efficacy as compared to other drug classes. By route of administration, feline atopic dermatitis treatment market is expected to be dominated by topical segment due to higher compliance. By distribution channel, feline atopic dermatitis treatment market is expected to be dominated by veterinary pharmacies due to higher footfall.

Feline Atopic Dermatitis Treatment Market: Regional Outlook

North America expected to dominate the global feline atopic dermatitis treatment market due to higher number of companion animals in the region. Europe feline atopic dermatitis treatment market due to increasing number of companion animals as well as higher treatment seeking rate as compared to other developing regions. Asia-Pacific is emerging feline atopic dermatitis treatment market due to rapidly increasing companion animal ownership and emerging countries such as India and China. Latin America is expected to experience gradual growth in the feline atopic dermatitis treatment market due to increasing product availability in the region. Middle East & Africa feline atopic dermatitis treatment market is expected to be least lucrative market due to least adoption of feline atopic dermatitis treatment.

Feline Atopic Dermatitis Treatment Market: Key Players

The key market players operating in the feline atopic dermatitis treatment market are: Bausch Health Companies Inc., Bayer AG, Pfizer Inc., Novartis AG, Eli Lily Company, Sanofi, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:
  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain
Regional analysis includes:
  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:
  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Table of Contents

250 Pages
1. Executive Summary
  1.1. Global Market Outlook
  1.2. Demand-side Trends
  1.3. Supply-side Trends
  1.4. Technology Roadmap Analysis
  1.5. Analysis and Recommendations
2. Market Overview
  2.1. Market Coverage / Taxonomy
  2.2. Market Definition / Scope / Limitations
3. Market Background
  3.1. Market Dynamics
    3.1.1. Drivers
    3.1.2. Restraints
    3.1.3. Opportunity 
    3.1.4. Trends
  3.2. Scenario Forecast
    3.2.1. Demand in Optimistic Scenario
    3.2.2. Demand in Likely Scenario
    3.2.3. Demand in Conservative Scenario
  3.3. Opportunity Map Analysis
  3.4. Investment Feasibility Matrix
  3.5. Value Chain Analysis
    3.5.1. Profit Margin Analysis
    3.5.2. Service Providers
  3.6. PESTLE and Porter’s Analysis
  3.7. Regulatory Landscape
    3.7.1. By Key Regions
    3.7.2. By Key Countries
  3.8. Regional Parent Market Outlook
4. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast, 2022-2032
  4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
  4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
    4.2.1. Y-o-Y Growth Trend Analysis
    4.2.2. Absolute $ Opportunity Analysis
5. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class
  5.1. Introduction / Key Findings
  5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Class, 2017-2021
  5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Class, 2022-2032
    5.3.1. Corticosteroids
    5.3.2. Antihistamines
    5.3.3. Antibiotics
  5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2017-2021
  5.5. Absolute $ Opportunity Analysis By Drug Class, 2022-2032
6. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration
  6.1. Introduction / Key Findings
  6.2. Historical Market Size Value (US$ Mn) Analysis By Route of Administration, 2017-2021
  6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032
    6.3.1. Oral
    6.3.2. Topical
    6.3.3. Injectable
  6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021
  6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032
7. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
  7.1. Introduction / Key Findings
  7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021
  7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032
    7.3.1. Veterinary Pharmacies
    7.3.2. Retail Pharmacies
    7.3.3. Online Pharmacies
  7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021
  7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032
8. Global Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region
  8.1. Introduction
  8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
  8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
    8.3.1. North America
    8.3.2. Latin America
    8.3.3. Europe
    8.3.4. East Asia
    8.3.5. South Asia & Pacific
    8.3.6. MEA
  8.4. Market Attractiveness Analysis By Region
9. North America Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    9.2.1. By Country
      9.2.1.1. U.S.
      9.2.1.2. Canada
    9.2.2. By Drug Class
    9.2.3. By Route of Administration
    9.2.4. By Distribution Channel
  9.3. Market Attractiveness Analysis
    9.3.1. By Country
    9.3.2. By Drug Class
    9.3.3. By Route of Administration
    9.3.4. By Distribution Channel
  9.4. Key Takeaways
10. Latin America Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    10.2.1. By Country
      10.2.1.1. Mexico
      10.2.1.2. Brazil
      10.2.1.3. Rest of Latin America
    10.2.2. By Drug Class
    10.2.3. By Route of Administration
    10.2.4. By Distribution Channel
  10.3. Market Attractiveness Analysis
    10.3.1. By Country
    10.3.2. By Drug Class
    10.3.3. By Route of Administration
    10.3.4. By Distribution Channel
  10.4. Key Takeaways
11. Europe Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    11.2.1. By Country
      11.2.1.1. Germany
      11.2.1.2. Italy
      11.2.1.3. France
      11.2.1.4. U.K.
      11.2.1.5. Spain
      11.2.1.6. BENELUX
      11.2.1.7. Russia
      11.2.1.8. Rest of Europe
    11.2.2. By Drug Class
    11.2.3. By Route of Administration
    11.2.4. By Distribution Channel
  11.3. Market Attractiveness Analysis
    11.3.1. By Country
    11.3.2. By Drug Class
    11.3.3. By Route of Administration
    11.3.4. By Distribution Channel
  11.4. Key Takeaways
12. East Asia Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    12.2.1. By Country
      12.2.1.1. China
      12.2.1.2. Japan
      12.2.1.3. South Korea
    12.2.2. By Drug Class
    12.2.3. By Route of Administration
    12.2.4. By Distribution Channel
  12.3. Market Attractiveness Analysis
    12.3.1. By Country
    12.3.2. By Drug Class
    12.3.3. By Route of Administration
    12.3.4. By Distribution Channel
  12.4. Key Takeaways
13. South Asia & Pacific Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    13.2.1. By Country
      13.2.1.1. India
      13.2.1.2. ASEAN
      13.2.1.3. Australia and New Zealand
      13.2.1.4. Rest of South Asia & Pacific
    13.2.2. By Drug Class
    13.2.3. By Route of Administration
    13.2.4. By Distribution Channel
  13.3. Market Attractiveness Analysis
    13.3.1. By Country
    13.3.2. By Drug Class
    13.3.3. By Route of Administration
    13.3.4. By Distribution Channel
  13.4. Key Takeaways
14. MEA Feline Atopic Dermatitis Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
  14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
  14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
    14.2.1. By Country
      14.2.1.1. GCC Countries
      14.2.1.2. Turkey
      14.2.1.3. South Africa
      14.2.1.4. Rest of MEA
    14.2.2. By Drug Class
    14.2.3. By Route of Administration
    14.2.4. By Distribution Channel
  14.3. Market Attractiveness Analysis
    14.3.1. By Country
    14.3.2. By Drug Class
    14.3.3. By Route of Administration
    14.3.4. By Distribution Channel
  14.4. Key Takeaways
15. Key Countries Feline Atopic Dermatitis Treatment Market Analysis
  15.1. U.S.
    15.1.1. Pricing Analysis
    15.1.2. Market Share Analysis, 2021
      15.1.2.1. By Drug Class
      15.1.2.2. By Route of Administration
      15.1.2.3. By Distribution Channel
  15.2. Canada
    15.2.1. Pricing Analysis
    15.2.2. Market Share Analysis, 2021
      15.2.2.1. By Drug Class
      15.2.2.2. By Route of Administration
      15.2.2.3. By Distribution Channel
  15.3. Mexico
    15.3.1. Pricing Analysis
    15.3.2. Market Share Analysis, 2021
      15.3.2.1. By Drug Class
      15.3.2.2. By Route of Administration
      15.3.2.3. By Distribution Channel
  15.4. Brazil
    15.4.1. Pricing Analysis
    15.4.2. Market Share Analysis, 2021
      15.4.2.1. By Drug Class
      15.4.2.2. By Route of Administration
      15.4.2.3. By Distribution Channel
  15.5. Germany
    15.5.1. Pricing Analysis
    15.5.2. Market Share Analysis, 2021
      15.5.2.1. By Drug Class
      15.5.2.2. By Route of Administration
      15.5.2.3. By Distribution Channel
  15.6. Italy
    15.6.1. Pricing Analysis
    15.6.2. Market Share Analysis, 2021
      15.6.2.1. By Drug Class
      15.6.2.2. By Route of Administration
      15.6.2.3. By Distribution Channel
  15.7. France
    15.7.1. Pricing Analysis
    15.7.2. Market Share Analysis, 2021
      15.7.2.1. By Drug Class
      15.7.2.2. By Route of Administration
      15.7.2.3. By Distribution Channel
  15.8. U.K.
    15.8.1. Pricing Analysis
    15.8.2. Market Share Analysis, 2021
      15.8.2.1. By Drug Class
      15.8.2.2. By Route of Administration
      15.8.2.3. By Distribution Channel
  15.9. Spain
    15.9.1. Pricing Analysis
    15.9.2. Market Share Analysis, 2021
      15.9.2.1. By Drug Class
      15.9.2.2. By Route of Administration
      15.9.2.3. By Distribution Channel
  15.10. BENELUX
    15.10.1. Pricing Analysis
    15.10.2. Market Share Analysis, 2021
      15.10.2.1. By Drug Class
      15.10.2.2. By Route of Administration
      15.10.2.3. By Distribution Channel
  15.11. Russia
    15.11.1. Pricing Analysis
    15.11.2. Market Share Analysis, 2021
      15.11.2.1. By Drug Class
      15.11.2.2. By Route of Administration
      15.11.2.3. By Distribution Channel
  15.12. China
    15.12.1. Pricing Analysis
    15.12.2. Market Share Analysis, 2021
      15.12.2.1. By Drug Class
      15.12.2.2. By Route of Administration
      15.12.2.3. By Distribution Channel
  15.13. Japan
    15.13.1. Pricing Analysis
    15.13.2. Market Share Analysis, 2021
      15.13.2.1. By Drug Class
      15.13.2.2. By Route of Administration
      15.13.2.3. By Distribution Channel
  15.14. South Korea
    15.14.1. Pricing Analysis
    15.14.2. Market Share Analysis, 2021
      15.14.2.1. By Drug Class
      15.14.2.2. By Route of Administration
      15.14.2.3. By Distribution Channel
  15.15. India
    15.15.1. Pricing Analysis
    15.15.2. Market Share Analysis, 2021
      15.15.2.1. By Drug Class
      15.15.2.2. By Route of Administration
      15.15.2.3. By Distribution Channel
  15.16. ASEAN
    15.16.1. Pricing Analysis
    15.16.2. Market Share Analysis, 2021
      15.16.2.1. By Drug Class
      15.16.2.2. By Route of Administration
      15.16.2.3. By Distribution Channel
  15.17. Australia and New Zealand
    15.17.1. Pricing Analysis
    15.17.2. Market Share Analysis, 2021
      15.17.2.1. By Drug Class
      15.17.2.2. By Route of Administration
      15.17.2.3. By Distribution Channel
  15.18. GCC Countries
    15.18.1. Pricing Analysis
    15.18.2. Market Share Analysis, 2021
      15.18.2.1. By Drug Class
      15.18.2.2. By Route of Administration
      15.18.2.3. By Distribution Channel
  15.19. Turkey
    15.19.1. Pricing Analysis
    15.19.2. Market Share Analysis, 2021
      15.19.2.1. By Drug Class
      15.19.2.2. By Route of Administration
      15.19.2.3. By Distribution Channel
  15.20. South Africa
    15.20.1. Pricing Analysis
    15.20.2. Market Share Analysis, 2021
      15.20.2.1. By Drug Class
      15.20.2.2. By Route of Administration
      15.20.2.3. By Distribution Channel
16. Market Structure Analysis
  16.1. Competition Dashboard
  16.2. Competition Benchmarking
  16.3. Market Share Analysis of Top Players
    16.3.1. By Regional
    16.3.2. By Drug Class
    16.3.3. By Route of Administration
    16.3.4. By Distribution Channel
17. Competition Analysis
  17.1. Competition Deep Dive
    17.1.1. Bausch Health Companies Inc.
      17.1.1.1. Overview
      17.1.1.2. Product Portfolio
      17.1.1.3. Profitability by Market Segments
      17.1.1.4. Sales Footprint
      17.1.1.5. Strategy Overview
        17.1.1.5.1. Marketing Strategy
        17.1.1.5.2. Product Strategy
        17.1.1.5.3. Channel Strategy
    17.1.2. Bayer AG
      17.1.2.1. Overview
      17.1.2.2. Product Portfolio
      17.1.2.3. Profitability by Market Segments
      17.1.2.4. Sales Footprint
      17.1.2.5. Strategy Overview
        17.1.2.5.1. Marketing Strategy
        17.1.2.5.2. Product Strategy
        17.1.2.5.3. Channel Strategy
    17.1.3. Pfizer Inc.
      17.1.3.1. Overview
      17.1.3.2. Product Portfolio
      17.1.3.3. Profitability by Market Segments
      17.1.3.4. Sales Footprint
      17.1.3.5. Strategy Overview
        17.1.3.5.1. Marketing Strategy
        17.1.3.5.2. Product Strategy
        17.1.3.5.3. Channel Strategy
    17.1.4. Novartis AG
      17.1.4.1. Overview
      17.1.4.2. Product Portfolio
      17.1.4.3. Profitability by Market Segments
      17.1.4.4. Sales Footprint
      17.1.4.5. Strategy Overview
        17.1.4.5.1. Marketing Strategy
        17.1.4.5.2. Product Strategy
        17.1.4.5.3. Channel Strategy
    17.1.5. Eli Lily Company
      17.1.5.1. Overview
      17.1.5.2. Product Portfolio
      17.1.5.3. Profitability by Market Segments
      17.1.5.4. Sales Footprint
      17.1.5.5. Strategy Overview
        17.1.5.5.1. Marketing Strategy
        17.1.5.5.2. Product Strategy
        17.1.5.5.3. Channel Strategy
    17.1.6. Sanofi
      17.1.6.1. Overview
      17.1.6.2. Product Portfolio
      17.1.6.3. Profitability by Market Segments
      17.1.6.4. Sales Footprint
      17.1.6.5. Strategy Overview
        17.1.6.5.1. Marketing Strategy
        17.1.6.5.2. Product Strategy
        17.1.6.5.3. Channel Strategy
    17.1.7. Bristol-Myers Squibb Company
      17.1.7.1. Overview
      17.1.7.2. Product Portfolio
      17.1.7.3. Profitability by Market Segments
      17.1.7.4. Sales Footprint
      17.1.7.5. Strategy Overview
        17.1.7.5.1. Marketing Strategy
        17.1.7.5.2. Product Strategy
        17.1.7.5.3. Channel Strategy
    17.1.8. Boehringer Ingelheim International GmbH
      17.1.8.1. Overview
      17.1.8.2. Product Portfolio
      17.1.8.3. Profitability by Market Segments
      17.1.8.4. Sales Footprint
      17.1.8.5. Strategy Overview
        17.1.8.5.1. Marketing Strategy
        17.1.8.5.2. Product Strategy
        17.1.8.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us